O75533 (SF3B1_HUMAN) Homo sapiens (Human)

Splicing factor 3B subunit 1 UniProtKBInterProSTRINGInteractive Modelling

1304 aa; Sequence (Fasta) ; (Isoform 2); 78 identical sequences

Available Structures

57 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Cryo-EM structure of human exon-defined spliceosome in the late pre-B state. Heteromer
O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
82-1304
100.0IHP;MG;GTP;ZN;
Cryo-EM Structure of the Activated Human Minor Spliceosome (minor Bact Complex) Heteromer
O15541; O43660; O60231; O75643; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q5RL73; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWG6; Q9BWJ5; Q9BZJ0; Q9H6L4; Q9HCG8; Q9P013; Q9P021; Q9UQ35; Q9Y388; Q9Y3B4;
82-1304
100.0IHP;GTP;MG;K;G5J;ZN;
Cryo-EM structure of human exon-defined spliceosome in the early B state. Heteromer
O43172; O43290; O43395; O43447; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q2TAY7; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
82-1304
100.0IHP;GTP;MG;ZN;
Cryo-EM structure of human exon-defined spliceosome in the mature pre-B state. Heteromer
O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
82-1304
100.0IHP;MG;GTP;ZN;
Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom. Heteromer
O15541; O43660; O60231; O75643; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9P013; Q9Y388; Q9Y3B4;
82-1304
100.0IHP;GTP;MG;ZN;
cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. Heteromer
O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
82-1304
100.0IHP;GTP;MG; 13×ZN;
Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom Heteromer
O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
82-1304
100.0IHP;ALA;GTP;MG; 10×ZN;
The cryo-EM structure of human pre-Bact complex Heteromer
O43660; O60306; O60870; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
87-1304
100.0GTP;MG;ZN;
The cryo-EM structure of human Bact-I complex Heteromer
O15541; O43660; O60231; O60306; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4;
87-1304
100.0IHP;GTP;MG;ZN;
Cryo-EM Structure of the human minor pre-B complex (pre-precatalytic spliceosome) U12 snRNP part Heteromer
P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q15393; Q15427; Q7RTV0; Q9BWG6; Q9BWJ5; Q9Y3B4;
101-1304
100.0ZN;
The Cryo-EM Structure of the Precusor of Human Pre-catalytic Spliceosome (pre-B complex) Heteromer
O43172; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
102-1304
100.0IHP;GTP;MG;
Human pre-Bact-2 spliceosome (SF3b/U2 snRNP portion) Heteromer
O60870; Q12874; Q13435; Q15393; Q15427; Q15428; Q7RTV0; Q8IYB3; Q8TAD8; Q99459; Q9BWJ5; Q9Y388; Q9Y3B4;
118-1304
100.0
Human pre-Bact-2 spliceosome Heteromer
O43660; O60306; O60508; O60870; O75643; P08579; P09661; P14678; P41223; P55081; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q8WYA6; Q96DI7; Q96NC0; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9BZL1; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
118-1304
100.0GTP;MG;IHP;
Cryo-EM structure of the cross-exon pre-B+5'ss+ATPgammaS complex Heteromer
O43172; O43290; O43395; O43447; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
394-1304
100.0
Cryo-EM structure of the cross-exon pre-B+5'ss complex Heteromer
O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
394-1304
100.0
Cryo-EM structure of the cross-exon pre-B+ATP complex Heteromer
O43172; O43290; O43395; O43447; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
394-1304
100.0
Cryo-EM structure of the cross-exon pre-B+5'ssLNG+ATPyS complex Heteromer
O43172; O43290; O43395; O43447; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
394-1304
100.0
Cryo-EM structure of the cross-exon pre-B complex Heteromer
O43172; O43290; O43395; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
394-1304
100.0
Substrate-bound A-like U2 snRNP Heteromer
Q12874; Q13435; Q15393; Q15428; Q7RTV0; Q9BWJ5; Q9Y3B4;
394-1304
100.0ZN;
human Bact spliceosome core structure Heteromer
O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
398-1304
100.011×ZN;MG;IHP;GTP;ADP;
human Bact spliceosome core structure Heteromer
O15541; O43660; O60508; P41223; Q13435; Q13573; Q15029; Q15393; Q15428; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9NW64; Q9P013; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
398-1304
100.0MG;IHP;GTP; 10×ZN;
human 17S U2 snRNP Heteromer
O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5; Q9Y3B4;
399-1304
100.0
Structure of a minimal SF3B core in complex with spliceostatin A (form I) Heteromer
Q15393; Q7RTV0; Q921M3; Q9BWJ5;
463-1304
100ZN;SCN;SJT;
Structure of a minimal SF3B core in complex with pladienolide D (form I) Heteromer
Q15393; Q7RTV0; Q9BWJ5;
463-1304
100T2Z;ZN;
Structure of a minimal SF3B core in complex with sudemycin D6 (form II) Heteromer
Q15393; Q7RTV0; Q9BWJ5;
463-1304
100ZN;T2W;
Structure of a minimal SF3B core in complex with sudemycin D6 (form I) Heteromer
Q15393; Q7RTV0; Q9BWJ5;
463-1304
100ZN;T2W;SCN;
Structure of a minimal SF3B core in complex with spliceostatin A (form II) Heteromer
Q15393; Q7RTV0; Q9BWJ5;
463-1304
100SJT;ZN;
SF3b core in complex with a splicing modulator Heteromer
Q15393; Q7RTV0; Q9BWJ5;
463-1304
100ZN;BGZ;
Crystal structure of the human SF3b core complex Heteromer
Q15393; Q7RTV0; Q9BWJ5;
463-1304
100.0ZN;K;
Structure of a minimal SF3B core in complex with the inactive modulator spliceostatin E (form I) Heteromer
Q15393; Q7RTV0; Q921M3; Q9BWJ5;
463-1304
10007I;ZN;
5'domain of human 17S U2 snRNP Heteromer
O43719; Q12874; Q13435; Q15393; Q7L014; Q7RTV0; Q9BWJ5;
463-1304
100ZN;
Human pre-Bact-1 spliceosome Heteromer
O14776; O43660; O75643; O95777; P08579; P09661; P14678; P41223; P52298; P55081; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; Q07955; Q09161; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q96DI7; Q96NC0; Q99459; Q9BWJ5; Q9BZL1; Q9NW64; Q9P013; Q9UK45; Q9Y2W2; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
465-1304
100.0IHP;GTP;MG;GTG;
Structure of the U2 5' module of the A3'-SSA complex Heteromer
Q12874; Q13435; Q15393; Q15427; Q15428; Q7RTV0; Q9BWJ5;
488-1304
100.0SJT;ZN;
The cryo-EM structure of human Bact-III complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
489-1304
100IHP;GTP;MG;ZN;
The cryo-EM structure of human post-Bact complex Heteromer
O43660; O60231; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q13573; Q15029; Q15393; Q15427; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
489-1304
100IHP;GTP;MG;ZN;
The cryo-EM structure of human Bact-II complex Heteromer
O15541; O43660; O60231; O60306; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
489-1304
100IHP;GTP;MG;ZN;
The cryo-EM structure of human Bact-IV complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
489-1304
100IHP;GTP;MG;ZN;
Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… Heteromer
O15541; O43660; O60231; O60306; O60508; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
490-1304
10012×ZN;IHP;GTP;MG;
The cryo-EM structure of the human 17S U2 snRNP Heteromer
O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5;
490-1304
1009B0;ZN;
The cryo-EM structure of the DDX42-SF3b complex Heteromer
Q15393; Q7RTV0; Q86XP3; Q9BWJ5;
490-1304
100ZN;
Structural organization of a late activated human spliceosome (Baqr, core region) Heteromer
O15541; O43660; O60231; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9NW64; Q9P013; Q9UQ35; Q9Y3C6;
490-1304
10012×ZN;IHP;GTP;MG;
The cryo-EM structure of human pre-17S U2 snRNP Heteromer
O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7RTV0; Q86XP3; Q9BWJ5;
490-1304
1009B0;ZN;
The cryo-EM structure of the human pre-A complex Heteromer
O75937; P08579; P08621; P09012; P09234; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q15637; Q7L014; Q7RTV0; Q9BWJ5;
490-1304
100ZN;SJT;
SF3b spliceosomal complex bound to E7107 Heteromer
Q15393; Q7RTV0; Q9BWJ5;
490-1304
100.09B0;ZN;K;
Cryo-EM structure of a pre-catalytic human spliceosome primed for activation (B complex) Heteromer
O43172; O43290; O43395; O43447; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55081; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q13123; Q15029; Q15393; Q2TAY7; Q6P2Q9; Q7RTV0; Q8NAV1; Q8WWY3; Q96DI7; Q96NC0; Q9BWJ5; Q9UK45; Q9Y333; Q9Y4Y9; Q9Y4Z0;
491-1304
100.0
Human 17S U2 snRNP 5' domain Heteromer
O43719; Q12874; Q13435; Q15393; Q7L014; Q7RTV0; Q9BWJ5;
491-1304
100ZN;
U2 snRNP after ATP-dependent remodelling Heteromer
Q12874; Q13435; Q15393; Q15428; Q7RTV0; Q9BWJ5;
1051-1304
100ZN;
NMR solution structure of the human spliceosomal protein complex p14-SF3b155 Heteromer
Q9Y3B4;
379-424
100
Branch Recognition by SF3b14 Heteromer
Q9Y3B4;
377-415
100ADE;
2.5 angstrom resolution structure of the spliceosomal protein p14 bound to region of SF3b155 Heteromer
Q9Y3B4;
377-415
100
3.0 angstrom resolution structure of a Y22M mutant of the spliceosomal protein p14 bound to a regio… Heteromer
Q9Y3B4;
381-415
100
human 17S U2 snRNP low resolution part Heteromer
O43719; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15427; Q15428; Q15459; Q7L014; Q9Y3B4;
399-419
100
U2AF65 UHM BOUND TO SF3B155 ULM5 Heteromer
P26368;
335-346
100
Crystal structure of the UHM domain of human SPF45 in complex with SF3b155-ULM5 Heteromer
Q96I25;
333-342
100
Crystal structure of human CAPERalpha UHM bound to SF3b155 ULM5 Heteromer
Q14498;
335-342
100K;CL;LYS;
Structure of HIV Tat-specific factor 1 U2AF Homology Motif bound to U2AF ligand motif 4 Heteromer
O43719;
291-297
100GOL;FMT;
Structure of HIV Tat-specific factor 1 U2AF Homology Motif bound to SF3b1 ULM5 Heteromer
O43719;
336-339
100PEG;GOL;

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7qtt.1.Cmonomer0.80490-1304
100.00
8y7e.1.Bmonomer0.70101-1304
100.00
6ah0.1.6monomer0.69102-1304
100.00
7n6g.17.Amonomer0.52618-1045
13.02
6iur.1.Bmonomer0.52608-1196
18.38
1b3u.1.Amonomer0.52687-1270
13.61

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28i0p.1.Vmonomer0.6087-140
99.29